Niraparib, Abiraterone Acetate

4 trials 2 recruiting LOncology

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

2 Recruiting

2 Completed trials

3 Sponsors

14 Countries

Phase III

Phase III: 4

Indications tested

Prostate cancer metastatic 3

Sponsors using this IMP

Janssen - Cilag International 2 Karolinska Institutet 1 UZ Leuven 1

All trials

4 total

Evaluation of the impact of metastasis-directed therapy in patients with castration-refractory prostate cancer and a maximum of 5 progressiv… Recruiting

2022-502254-13-00 Phase III 1 country UZ Leuven
ProBio: An outcome-adaptive and randomised multi-arm biomarker driven study in patients with metastatic prostate cancer Recruiting

2023-506857-40-00 Phase III 3 countries Karolinska Institutet
A Phase 3 Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment … Ended

2023-506365-64-00 Phase III 13 countries Janssen - Cilag International
A Phase 3 Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment … Ended

2023-503254-12-00 Phase III 10 countries Janssen - Cilag International

Showing 1–4 of 4 trials

← All drugs A–Z